TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis
Sci. rep. (Nat. Publ. Group); 12 (1), 2022
ABSTRACT: TREML4 and other members of the triggering receptor expressed in the myeloid cell family are associated with a risk of atherosclerosis and progression in coronary artery disease, acute coronary syndrome, and coronary artery calcification. Herein, the relationship between TREML4 expression and i...